Literature DB >> 6505992

Cryptogenic fibrosing alveolitis: pattern of disease in the lung.

P H Wright, M Buxton-Thomas, L Kreel, S J Steel.   

Abstract

The distribution of disease has been studied in 10 patients with histologically confirmed cryptogenic fibrosing alveolitis by means of computed tomography of the lungs, gallium 67 uptake scintigraphy, and ventilation and perfusion scintigraphy. The findings of computed tomography and scintigraphy showed no correlation with the UICC/Cincinnati grades of the plain chest radiographs, even when these were supplemented with information from lateral and oblique chest films. Computed tomography showed subpleural shadowing in every patient except one who had responded well to corticosteroid treatment. Subpleural shadowing was commoner in the inferior and posterior parts of the lung lobes and was commonest in the posterior lower subpleural areas. The central lung showed three types of change--firstly, a dense shadowing, which was sometimes associated with much increased gallium uptake; secondly, dilated smaller airways with small bullae, suggesting airway disease; and, thirdly, gross bullous change.

Entities:  

Mesh:

Year:  1984        PMID: 6505992      PMCID: PMC459937          DOI: 10.1136/thx.39.11.857

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  OPEN-LUNG BIOPSY IN DUFFUSE PULMONARY DISEASE.

Authors:  E A GAENSLER; V B MOISTER; J HAMM
Journal:  N Engl J Med       Date:  1964-06-18       Impact factor: 91.245

2.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS.A CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL STUDY BASED ON 45 PATIENTS.

Authors:  J L LIVINGSTONE; J G LEWIS; L REID; K E JEFFERSON
Journal:  Q J Med       Date:  1964-01

3.  Trephine biopsy of the lung and pleura.

Authors:  S J Steel; D P Winstanley
Journal:  Thorax       Date:  1969-09       Impact factor: 9.139

4.  Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.

Authors:  E D Bateman; M Turner-Warwick; P L Haslam; B C Adelmann-Grill
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

Review 5.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

6.  Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features.

Authors:  P H Wright; B E Heard; S J Steel; M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1981-01

7.  Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients.

Authors:  E A Gaensler; C B Carrington
Journal:  Ann Thorac Surg       Date:  1980-11       Impact factor: 4.330

8.  Trephine biopsy for diffuse lung lesions.

Authors:  S J Steel; D P Winstanley
Journal:  Br Med J       Date:  1967-07-01

9.  Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage.

Authors:  B R Line; J D Fulmer; H Y Reynolds; W C Roberts; A E Jones; E K Harris; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1978-08

10.  Computerized tomography using the EMI general purpose scanner.

Authors:  L Kreel
Journal:  Br J Radiol       Date:  1977-01       Impact factor: 3.039

  10 in total
  2 in total

1.  Computed tomography based estimates of regional gas and tissue volume of the lung in supine subjects with chronic airflow limitation or fibrosing alveolitis.

Authors:  A B Millar; B Fromson; B A Strickland; D M Denison
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

Review 2.  Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis.

Authors:  Andrew J Ghio; Elizabeth N Pavlisko; Victor L Roggli; Nevins W Todd; Rahul G Sangani
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.